Stevens Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Stevens Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$112.21 - $151.95 $1.66 Million - $2.24 Million	-14,761 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$106.67 - $151.68 $1.31 Million - $1.87 Million	12,297 Added 499.07%	14,761 $1.76 Million
Q4 2018 Feb 06, 2019	BUY	$97.32 - $148.76 $239,796 - $366,544	2,464 New	2,464 $269,000
Q3 2018 Nov 13, 2018	SELL	$115.31 - $161.51 $733,832 - $1.03 Million	-6,364 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$71.74 - $153.69 $65,211 - $139,704	909 Added 16.66%	6,364 $841,000
Q1 2018 May 08, 2018	BUY	$54.02 - $82.27 $294,679 - $448,782	5,455 New	5,455 $404,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.